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Abstract
We have developed a sequence conservation-based artificial neural network predictor called NetDiseaseSNP which classifies
nsSNPs as disease-causing or neutral. Our method uses the excellent alignment generation algorithm of SIFT to identify
related sequences and a combination of 31 features assessing sequence conservation and the predicted surface accessibility
to produce a single score which can be used to rank nsSNPs based on their potential to cause disease. NetDiseaseSNP
classifies successfully disease-causing and neutral mutations. In addition, we show that NetDiseaseSNP discriminates cancer
driver and passenger mutations satisfactorily. Our method outperforms other state-of-the-art methods on several disease/
neutral datasets as well as on cancer driver/passenger mutation datasets and can thus be used to pinpoint and prioritize
plausible disease candidates among nsSNPs for further investigation. NetDiseaseSNP is publicly available as an online tool as
well as a web service: http://www.cbs.dtu.dk/services/NetDiseaseSNP
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Introduction
A non-synonymous single nucleotide polymorphism (nsSNP) is a
single nucleotide substitution occurring inside the coding region of
a gene which causes an amino acid substitution in the
corresponding protein product. In the current work, we include
somatic single point mutations in this overall concept. An amino
acid change can cause a structural or functional change in the
protein product which potentially results in a minor or major
phenotypic change. It is also entirely possible that a nsSNP has no
phenotypic effect at all [1]. With the recent increase in the amount
of nsSNP data [2–4], algorithms for the automatic prediction and
prioritization of these phenotypic consequences are therefore
valuable. For example, the Sorting Intolerant from Tolerant
(SIFT) algorithm [5–8] is arguably the most well recognized tool
for prediction of disease causing nsSNPs due to its high
performance and its easy applicability to large datasets, which is
a result of an excellent alignment generation step which is
specialized for analysing disruption by nsSNPs of conserved
sequences. Furthermore, SIFT constitutes the basis for other
prediction methods where the output categories have further been
expanded from classifying between disease causing and neutral to
predict activity changes [9]. More recently, machine learning
algorithms have found practical use for many tasks within
sequence analysis and pattern recognition due to their ability to
capture sequence correlations, which are present in numerous
acceptor site motifs and other functional features [10]. Several
methods for predicting phenotypic changes caused by nsSNP have
been published during the last decade such as PolyPhen-2 [11,12],
SNAP [13] and Mutation Assessor [14]. Some methods are
specifically tuned for certain diseases such as cancer [15] or
particular protein subfamilies, as is the case of the methods to
predict the pathogenicity of mutations in protein kinases [16,17].
In addition, several meta-servers have been published lately. These
methods combine a weighted selection individual classifiers, such
as the ones presented above, and generate a consensus prediction
of the impact of mutations, which usually yields increased
performances. Condel [18], Consensus [19] and PON-P [20]
constitute successful examples of the latter.
Another tool that maps functional changes caused by nsSNPs is
EPipe. The EPipe server is a versatile tool which performs
comparative analysis of protein variants resulting from genomic
variation (e.g. nsSNPs), somatic mutations, alternative splicing or
protein families from one or more organisms. The server is
publicly available at http://www.cbs.dtu.dk/services/EPipe. The
input proteins are first processed by a number of analysis and
prediction methods and results are mapped onto a multiple
alignment showing only the differential protein feature space of
e.g. post-translational modification (PTM) sites or protein sorting
signals.
Several public databases containing nsSNP data with pheno-
typic impact exist and among the most widely used are the Single
Nucleotide Polymorphism database (dbSNP) [21] and the
Universal Protein Resource (UniProt) [22]. Commercial databases
such as the Human Gene Mutation Database (HGMD) Profes-
sional [23] provide valuable disease associated information.
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SNPedia (http://www.snpedia.com) is an example of a database
that contains SNP data with linked phenotypes which are both
disease and non-disease related. Furthermore databases of SNPs or
mutations for specific diseases such as cancer also exist e.g. the
Catalogue Of Somatic Mutations In Cancer (COSMIC) [24]. The
COSMIC dataset can be assumed to be enriched for cancer driver
mutations as compared to large scale somatic mutation discovery
datasets which can be expected to contain a fair number of
passenger mutations [9]. These databases can be used for training
and evaluation of methods for prediction of phenotypic changes
caused by nsSNPs that have a functional phenotypic impact and
can be causative in diseases.
Among structural information related features protein surface
accessibility of the SNP site obtained from 3D-structure has been
shown to be important for prediction of disease causing nsSNPs
[1,11–13,25–27]. When no 3D-structure is available, a prediction
of surface accessibility may be expected to increase the perfor-
mance of disease SNP predictions.
In the current study we present NetDiseaseSNP, a sequence
conservation-based predictor of the pathogenicity of mutations
which exploits the predictive power of artificial neural networks
(ANNs). Our method derives sequence conservation from a PSSM
based on the alignment algorithm of SIFT, which is complement-
ed with the calculation of surface accessibility by our previously
published predictor NetSurfP [28]. This approach provides
NetDiseaseSNP with the potential to extract all relevant informa-
tion directly from protein sequences. In addition, we show that our
predictor outperforms some of the current state-of-the art disease
SNP predictors in different scenarios.
Results and Discussion
Feature selection and description of the Neural Network
Here we present NetDiseaseSNP, a method for the prediction of
the pathogenicity of mutations based on sequence conservation
and surface accessibility. The system derives sequence conserva-
tion from a PSSM based on the alignment algorithm of SIFT. This
information is complemented with the calculation of surface
accessibility by our previously published predictor NetSurfP [28].
Finally, the system exploits the predictive power of artificial neural
networks (ANNs) to calculate the likelihood of mutations to alter
protein function.
Sequence conservation and surface accessibility have proven to
be valuable for methods predicting phenotypic changes caused by
nsSNPs [1]. Evolutionary information is typically gathered by an
alignment step and used to produce a position specific scoring
matrix (PSSM). For example, the alignment algorithm of SIFT is
designed to gather an optimal set of distantly related sequences [7]
and in doing so, it collects sequence specific information which can
be used to distinguish conserved from variable positions in the
protein investigated. In the absence of specific alignments for the
protein being considered, generic substitution matrices such as
Blosum62 may be employed, albeit with a lower performance [5].
We evaluated the performance of PSSMs generated by both
SIFT and PSI-BLAST when used as input to the ANNs. We
observed that the PSSMs generated by SIFT produced better
results and consequently were preferred for the predictor. We
evaluated the performance when NetSurfP uses its own PSSMs or
the ones generated by SIFT PSSMs with a two-sided binomial test
where the investigated SNPs were SNPs predicted in opposite
categories when the NetSurfP output was either used as input or
omitted. Polymorphisms predicted correctly when the NetSurfP
output was used as input was thus counted as a success and
polymorphisms predicted correctly when no NetSurfP output was
used were counted as a failure. In both cases, we observed a
significant increase in the performance. The p-values for NetSurfP
PSSMs and SIFT PSSMs were found to be: 1:10{5 and 4:10{3,
respectively and that the results were comparable (p-value 0.17).
Different input to the ANNs was tested and the optimal
encoding of the features was found to be an extensive feature-
space comprising 31 properties calculated directly from the protein
sequences. Each of these properties corresponds to an input
neuron in the ANN used to build NetDiseaseSNP as follows: Two
input neurons receive the log-odds scores for the native and
mutant amino acids, respectively. A log-odds score below zero
suggests that the given amino acid is disfavoured at the given
position.
Additionally, 20 input neurons which receive the log-odds
scores for each amino acid in the analyzed position in the sequence
alignment i.e. the row in the PSSM corresponding to the SNP
position. This gives our predictor the potential to derive a measure
of the sequence conservation at the SNP site and to learn which
amino acids are similar or dissimilar meaning that these amino
acids are favourable or disfavourable substitutions with respect to
e.g. physiochemical and structural properties, from a purely data
driven approach. The combination of these 22 log-odds scores
thus makes it possible for our predictor to compare the native and
SNP amino acids to the 20 standard amino acids based on the
values of the log-odds scores and investigate which of them are
more likely tolerated according to the alignment. Based on this
NetDiseaseSNP has the potential to infer physiochemical and
structural properties for the native and SNP amino acid.
The significance of the above mentioned aspects of the
alignment will then be correlated with the disease causing
potential of the SNP by our predictor. This data driven learning
process can be assumed — provided enough data — to give a
better and more detailed picture of these correlations than e.g.
encoding the native and SNP amino acids in a reduced alphabet
based on physiochemical properties where e.g. a combined log-
odds score could be calculated for E and D.
Providing the 20 standard amino acid log-odds scores plus the
log-odds scores for the native and SNP amino acids hence gives a
more informative and detailed description of the environment for
the site of the SNP than just using the normalized probability for
the SNP amino acid for deciding whether a SNP is disease causing
or not — as is done by the SIFT algorithm. The same arguments
as mentioned above for physiochemical properties apply for e.g.
structural properties (e.g. small/large amino acid) of native and
SNP amino acids.
NetDiseaseSNP encodes in one input neuron the SIFT score
(normalized probability) for the SNP amino acid. This score is
sufficient on its own to discriminate between neutral and disease
variants very accurately [5]. Another input neuron encodes the
median conservation score (RcMedian) from the SIFT output.
This feature is discussed in the original publications [6,7]. It is
worth pointing out that this score can be regarded as a confidence
score for the SIFT score. The optimal diversity of the sequences in
the alignment is achieved for a value of the RcMedian score
between 2.75 and 3.00. For values above 3.00 the diversity in the
alignment becomes too small and the performance of the
predictions made by SIFT based on the SIFT score decreases.
On the other hand if the RcMedian score is below 2.75 then the
alignment has become too diverse and SIFT will in these cases
predict too many neutral SNPs and hence predict more
experimentally verified disease SNPs as neutral SNPs. NetDisea-
seSNP is thus trained to have the potential to make its own
conclusions about how significant the SIFT score value is and thus
to decide if it is better to trust e.g. the surface accessibility
Disease SNP Prediction by NetDiseaseSNP
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prediction more in cases where the RcMedian score indicates that
the SIFT score is less reliable. NetDiseaseSNP is also provided
(one input neuron) with the conservation score for the SNP site
which gives a measure of how conserved all amino acids are at the
SNP site as opposed to the SIFT score which only compares the
probability for the SNP amino acid and the most frequent amino
acid in the alignment. The SIFT and conservation scores may thus
supplement each other by highlighting slightly different aspects of
the conservation at the SNP site in the alignment. The
conservation score for the SNP site is thus another example of
how attempts are made for our predictor to use all relevant
information which is available in the alignment created by SIFT.
Finally, NetSurfP predictions for the non-mutated native query
sequences are also encoded. Two neurons receive the relative
surface accessibility and the associated reliability score of the
mutated residue. Two additional pairs of input neurons process
this information for the residues directly adjacent to the mutated
one. The main advantage of using predicted surface accessibility as
opposed to e.g. data from a PDB file is the possibility to generate
predictions for proteins where no 3D structure is yet available,
which is often the case. Consequently, a total of 6 input neurons
encode the information from NetSurfP.
The other input features may as discussed above provide
information about the physiochemical and structural significance
of the amino acid change which can then be correlated with the
surface accessibility of the SNP site. This type of correlations
would provide information about e.g. a hydrophobic amino acid
inside the protein being changed to a charged amino acid — such
substitutions could potentially be damaging to the protein.
Ranking mutations with NetDiseaseSNP
The output score of NetDiseaseSNP can be used to rank and
prioritize polymorphisms for further investigation. The ANNs of
our predictor will generate an output value close to 1 if the
combination of features describing that particular mutation
suggests that it might be involved in disease, and close to 0 for
neutral mutations. The distance to the prediction threshold (0.5)
can be used as an indication of the reliability of the prediction, as
observed in Figure 1.
Softening of target values
The target values in the training set were optimized by a
procedure that we refer to as softening of target values. This
optimization resulted in a better separation of predicted scores
(Figure 1). For each step in the softening procedure an increase in
performance was observed and it was checked that this increase in
performance was significant by performing a two-sided binomial
test (data not shown). In this test a correct prediction for the given
SNP in the current step and a wrong prediction in the previous
step were counted as a success, and a wrong prediction for the
given SNP in the current step and a correct prediction in the
previous step were counted as a failure. It should be noted that the
softening procedure was only applied to the training set, and not
test or evaluation sets. 36 ANNs were selected from the last step of
the softening procedure and used to build the final version of
NetDiseaseSNP. The number of hidden neurons for these ANNs
lies in the range from 8 to 38. This procedure is explained in detail
in the Materials and Methods section.
The softening of target values procedure is used to move the
target values in the training set for the worst wrongly predicted
SNPs closer to the threshold value of 0.5 to reduce the
contribution of these to the error function in the backpropagation
algorithm. The new target values are generated from the average
test output values — and not from the average evaluation output
values to avoid optimization on the evaluation set. The idea
behind the softening of target values procedure is thus to correct
for polymorphisms in the dataset which are wrongly classified
(disease/neutral) in the experimental studies e.g. undiscovered
disease polymorphisms but also polymorphisms which are not
directly causative of a disease e.g. SNPs dependent on other SNPs
to cause a disease. The increased density in Figure 1 of FNs with
output values close to 0 and FPs with output values close to 1 when
comparing step 0 and 4 in the softening of target values procedure
could be attributed to such SNPs.
By softening the targets values stepwise starting with the most
incorrectly predicted polymorphisms the ANNs will gradually
become more robust in their predictions thus making it possible to
address less wrongly predicted polymorphisms. The increased
robustness of the ANNs is evident from the significant increase in
performance for each step in the procedure and the better
separation of the output values as shown in Figure 1.
Performance of NetDiseaseSNP
We evaluated the performance of NetDiseaseSNP using a 4-fold
cross-validation approach on a dataset comprising 58872 muta-
tions from HGMD and UniProt for which their character as
disease-causing or neutral has been described. This dataset was
complemented with 18468 neutral human-rodent differences to
balance the resulting datasets (Table 1). Further details on the
generation of the datasets and the construction of the associated
PSSMs can be found in the Materials and Methods section. We
evaluated the performance achieved by our classifier according to
well established measures [29] and we observed that NetDisea-
seSNP is capable of classifying disease-causing mutations from
neutral polymorphisms satisfactorily. Accuracy (0.82), precision
(0.83), sensitivity (0.80) and specificity (0.83) are fairly high and
well balanced. MCC and F-score for this dataset were 0.64 and
0.81 respectively. These results have been summarized in Table 2.
In addition, we evaluated the performance of our classifier only
in the cases where there is abundant evolutionary information so
that SIFT PSSM can be generated. For this subset of mutations
the performance measures increase substantially. Specificity and
Sensitivity become 82% and 85% respectively, yielding a F-score
of 0.83, whereas MCC rises to 0.67 as described in Table 3.
Furthermore, the performance of the classifier can go to MCC
values reaching 0.70 when a consensus prediction between SIFT
and NetDiseaseSNP can be obtained, which is by far the most
common scenario. Contrarily, when a SIFT alignment has been
used as input to NetDiseaseSNP, but the two predictors disagree
on the given prediction the performance of NetDiseaseSNP is
MCC=0.25. Our predictor has some prediction potential for
SNPs generated from a Blosum62 matrix, however, the perfor-
mance dropped significantly (MCC=0.42) and predictions should
be used with some caution. Since the performance of NetDisea-
seSNP is low on these two latter types of SNPs, they are therefore
not included in the default output from NetDiseaseSNP.
Additionally, we benchmarked NetDiseaseSNP against a
number of state-of-the-art predictors of the pathogenicity of
mutations including SIFT [5], PolyPhen-2 [11,12], SNAP [13]
and Mutation Assessor [14]. These methods were chosen because
they are among the most widely used methodologies but also
because they approach the pathogenicity prediction problem from
different angles as we have described previously. The results of this
analysis can be found in Table 2 and Table 3 depending on
whether Blosum62 generated predictions are considered or
excluded from the analysis, respectively. Interestingly, NetDisea-
seSNP outperformed the aforementioned predictors and demon-
strated a fair balance between specificity and sensitivity.
Disease SNP Prediction by NetDiseaseSNP
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For the rarely occurring sequences longer than 2000 amino
acids multiple alignments are harder to obtain through SIFT and
Blosum62 matrix data is always used by NetDiseaseSNP to encode
variations in such proteins. Splitting such long proteins into their
functional domains will allow SIFT to generate the required
PSSMs.
A detailed performance comparison between NetDiseaseSNP
and SIFT is available in Table S1 in File S1.
Prediction of cancer driver and passenger mutations
In order to test the ability of distinguishing driver from
passenger mutations we evaluated NetDiseaseSNP with the same
dataset used for the development of CanPredict [15], a cancer-
associated missense mutation predictor.This dataset consists of
cancer mutations from the COSMIC cancer dataset which are
assumed to be driver mutations and SNPs from dbSNP with a
minor allele frequencyw20% which are considered passenger
mutations. After verifying the nsSNPs from dbSNP against
Figure 1. Softening of target values procedure. Density plot showing the change in the distribution of the output values for known disease and
neutral SNPs in the running evaluation set during the softening of target values procedure. Step 0 is the distribution of output values before the
procedure and step 4 is the distribution at the end of the procedure for the final version of NetDiseaseSNP. Predicted scores above the threshold of
0.5 are true positives for data shown in red graphs, whereas scores above 0.5 in the blue graphs represent false positives. It is seen that predicted
scores are dragged more to the extreme ends (0–1) after applying the procedure ‘softening of target values’.
doi:10.1371/journal.pone.0068370.g001
Table 1. Composition of the training sets.
Neutral Disease
Source SNPs Proteins SNPs Proteins
UniProt 20202 7513 6904 1847
HGMD — — 31766 1593
Human-rodent 18468 2260 — —
All 38670 7979 38670 3440
Contribution of each source database to the training datasets. The table shows
the number of SNPs, as well of the number of affected proteins, in each of the
prediction categories, namely, neutral and disease-associated.
doi:10.1371/journal.pone.0068370.t001
Table 2. Benchmark of NetDiseaseSNP.
Method N Accuracy Precision Sensitivity SpecificityF-score MCC
NetDiseaseSNP 77340 0.82 0.83 0.80 0.83 0.82 0.64
SIFTnd 75647 0.82 0.83 0.79 0.84 0.81 0.63
SIFTsd 24584 0.67 0.41 0.54 0.72 0.47 0.24
SNAP 25141 0.51 0.33 0.84 0.40 0.48 0.22
Polyphen2 11012 0.61 0.09 0.81 0.60 0.17 0.18
MutationAssessor 40693 0.64 0.30 0.86 0.60 0.44 0.34
Performance of NetDiseaseSNP and other state-of-the art predictors. The
evaluation was performed on all variants in the evaluation set. This includes
data obtained from Blosum62 matrices.
doi:10.1371/journal.pone.0068370.t002
Disease SNP Prediction by NetDiseaseSNP
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Ensembl v.54, NCBI Build 36 our final dataset consisted of 997
driver mutations and 3404 passenger mutations.
From the results described in Table 4 we can conclude that
NetDiseaseSNP can distinguish cancer driver mutations from
passenger mutations very accurately (0.85). This observation also
stands true when the ability to identify drivers is evaluated:
precision (0.81) and recall (0.62). This well balanced performance
leads to a f-score of 0.70 and a MCC of 0.61. We benchmarked
the prediction capabilities of NetDiseaseSNP with respect to other
state-of-the-art methodologies to predict the pathogenicity of
mutations. These included SIFT [5], PolyPhen-2 [11,12], SNAP
[13] and Mutation Assessor [14]. From the analysis of the results,
we can conclude that NetDiseaseSNP outperformed the rest of
methods. In particular, we observed that the predictions are
balanced in terms of specificity and sensitivity, whereas the other
predictors either show a tendency to predict a big number of
mutations as disease causing, i.e. allowing for erroneous predic-
tions, or to be very conservative with their predictions, i.e. predict
fewer mutations for which their pathogenicity is very clear. The
performance of NetDiseaseSNP on mutations where Blosum62
matrix data has been used as input drops significantly
(MCC=0.11). We can conclude from this result that the
predictions generated by NetDiseaseSNP from Blosum62 matrix
data should be used with caution. A detailed performance
comparison between NetDiseaseSNP and SIFT can be found in
Table S3 in File S1.
The ability of our predictor to predict cancer driver mutations
from passenger mutations was initially tested on the COSMIC
cancer mutation dataset [24] where we in the test assumed that
variants predicted to be disease mutations are predicted driver
mutations and that variants predicted to be neutral mutations are
predicted passenger mutations. The COSMIC dataset can be
assumed to be enriched for driver mutations as compared to large
scale somatic mutation discovery datasets which can be expected
to contain a fair number of passenger mutations [9]. NetDisea-
seSNP was hence shown to predict significantly more driver
mutations than passenger mutations in the COSMIC dataset.
Notice though that some predicted disease mutation might not be
driving the cancer development but instead cause other diseases.
Figure 2 shows the number of predicted passenger (neutral) and
driver (disease) mutations for the different tissue types in the
COSMIC cancer dataset. Interestingly, the only tissue type which
has approximately the same number of predicted passenger and
driver mutations is breast tissue while the other tissue types have
more predicted driver mutations than passenger mutations. The
results are discussed in detail in Table S2 in File S1.
Implementation of the method as a web server
NetDiseaseSNP is publicly available as an online tool as well as
a web service: http://www.cbs.dtu.dk/services/NetDiseaseSNP.
Sequences are submitted in fasta format, whereas variant data is
encoded according to the following space-separated format:
‘Accession’, ‘native amino acid’, ‘position’, ‘variant amino acid’.
Individual queries can be submitted by pasting sequence and
variation data in the corresponding text-boxes, however, it is also
possible to perform batch submissions where a fasta file and
variant file can be uploaded from the local computer. The jobs are
parallelized and handled by a queuing system. Performing the
whole calculations on a standard protein of 250 amino acids with
any number of variants is expected to provide results within
15 minutes in the currently available hardware. In addition, a
cache has been implemented to speed up the calculation of
recurrent queries. The output from NetDiseaseSNP contains the
original input as well as the predictions in a simple space-separated
format. The predictions consist of the NetDiseaseSNP score and the
predicted category for each mutation (disease/neutral). NetDisea-
seSNP score ranges from 0 to 1 where scores§0:5 are indicative of
the mutation being involved in disease, whereas neutral mutations
are associated to values below this threshold. The default output
from NetDiseaseSNP only displays predictions where NetDisea-
seSNP and SIFT agree. This default behaviour includes most
variants and allows the user to focus only on the most reliable
predictions since NetDiseaseSNP has the highest performance for
such variants. Nevertheless, this default settings can be easily
customizable to include variants where NetDiseaseSNP and SIFT
disagree or predictions based on Blosum62 matrices.
Conclusion
The amount of variant data is growing fast and algorithms for
predicting and prioritizing phenotypic changes caused by these
variants are therefore becoming increasingly valuable. We have
developed NetDiseaseSNP, a sequence conservation-based pre-
diction of the pathogenicity of mutations that exploits the
predictive power of artificial neural networks (ANNs). NetDisea-
seSNP derives sequence conservation from a PSSM based on the
alignment algorithm of SIFT, which is complemented with the
calculation of surface accessibility by NetSurfP [28]. This
combined set of features describes the mutations very efficiently
and allows our method to predict the implication of mutations in
disease very accurately. Additionally, we have shown that
NetDiseaseSNP is able to discriminate between cancer driver
and passenger mutations accurately. In addition, we have show
that our predictor outperforms some of the current state-of-the art
disease SNP predictors in both datasets.
Table 3. Benchmark of NetDiseaseSNP: SIFT PSSMs.
Method N Accuracy Precision Sensitivity Specificity F-scoreMCC
NetDiseaseSNP 67119 0.83 0.84 0.82 0.85 0.83 0.67
SIFTnd 67119 0.82 0.83 0.79 0.84 0.81 0.63
SIFTsd 22020 0.68 0.41 0.54 0.73 0.46 0.25
SNAP 22417 0.52 0.32 0.83 0.41 0.46 0.22
Polyphen-2 10042 0.61 0.07 0.80 0.60 0.14 0.16
MutationAssessor 35657 0.64 0.29 0.86 0.60 0.43 0.33
Performance of NetDiseaseSNP and other state-of-the art predictors. The
evaluation was performed only on the variants for which a SIFT PSSM was
available. This excludes data obtained from Blosum62 matrices.
doi:10.1371/journal.pone.0068370.t003
Table 4. Benchmark of NetDiseaseSNP: Cancer drivers and
passengers.
Method N Accuracy Precision Sensitivity Specificity F-score MCC
NetDiseaseSNP 4401 0.85 0.62 0.81 0.86 0.70 0.61
SIFTnd 4036 0.84 0.63 0.79 0.85 0.70 0.60
SIFTsd 2778 0.78 0.37 0.64 0.81 0.47 0.36
SNAP 2835 0.57 0.24 0.85 0.51 0.37 0.26
Polyphen-2 1686 0.78 0.06 0.85 0.78 0.11 0.19
MutationAssessor 1587 0.66 0.19 0.86 0.64 0.31 0.29
Performance of NetDiseaseSNP and other state-of-the art predictors on the
cancer-specific dataset from CanPredict [15].
doi:10.1371/journal.pone.0068370.t004
Disease SNP Prediction by NetDiseaseSNP
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In summary, we have thus demonstrated that our predictor can
be used to pinpoint and prioritize plausible disease candidates
among nsSNPs for further investigation. NetDiseaseSNP is publicly
available at http://www.cbs.dtu.dk/services/NetDiseaseSNP
Materials and Methods
Generation of the training dataset
The training dataset was obtained from HGMD Professional
[23] and UniProt [22]. In order to increase the quality of the
training datasets, we performed some filtering and curation on
these datasets. nsSNPs from HGMD which were reported as not
necessarily causative of disease were discarded. These were
identified by a matching ‘assoc’ or ‘?’ in the disease field. After
this initial filtering, we considered 32484 disease mutations in 1606
proteins from HGMD and 18884 disease mutations and 21851
neutral polymorphisms affecting a total of 8705 proteins from
UniProt. A homology reduction procedure was applied to
eliminate duplicated variations after the combination of the two
different datasets. Iterative BLAST i.e. PSI-BLAST [30] was run
for each protein in the HGMD and UniProt datasets with an
e{valuev1:10{15, 3 iterations and the NCBI non-redundant
protein database (nr, July 2008) was used as the sequence
database. At this point and due to technical issues, two proteins
longer than 9999 amino acids were excluded from the analysis and
78 disease and 214 neutral variations were not considered. The
PSSMs from this PSI-BLAST run were used to combine the
HGMD and UniProt datasets in a homology reduction procedure
where the unique key for a SNP was defined as the 20 standard
amino acid log-odds scores (rounded to nearest integer) in the
PSSM for the SNP position and the one letter amino acid symbols
for the native and SNP amino acids. Thus, a vector of length 22
was constructed for each SNP. Incongruences between the
databases were resolved assuming that HGMD annotation is
more accurate than UniProt, and that mutations annotated as
disease and neutral might be undiscovered disease SNPs at the
time of the analysis. 557 mutations from HGMD corresponded to
neutral variations in UniProt and 24 variations were annotated
both as neutral and disease-associated in UniProt. All these cases
were considered disease-associated mutations in our training set.
After the homology reduction step, 11682 UniProt disease SNPs
were not considered due to similarity to an existing HGMD
disease SNPs.
Even though ANNs correct for biases during training,
experience has shown that better performance is achieved with
balanced datasets comprising the same number of disease and
neutral SNPs. Hence, we complemented our training set with
neutral SNPs identified as mismatches in a pairwise alignment
between human and rodent sequences. These pairwise alignments
were generated from a BLAST search for each human UniProt
proteins in the set, against the rodent (mouse and rat) sequences in
UniProt. Then a reciprocal BLAST search was performed with
the UniProt rodent sequence hits as query sequences against the
human UniProt sequences. Both BLAST searches were con-
strained using e{valuev1:10{10 and sequence identityw90%.
Mismatches from these alignments were assigned as additional
neutral SNPs, provided that no known disease associated SNPs exist
for the position of the given variation. From that set of human-
rodent SNPs we randomly selected 18468 additional unique data
points according to the homology criteria mentioned above until the
two datasets presented the same number of mutations.
Table 1 shows the composition of the final training set which in
total consists of 77340 SNPs in 10003 proteins. We have included
this training set as part of the documentation of NetDiseaseSNP,
from where it can be downloaded for further analysis.
Figure 2. Prediction by NetDiseaseSNP on COSMIC. Number of predicted passenger (neutral) and driver (disease) mutations for the different
tissue types in the COSMIC cancer dataset. Our recommendation that predicted disease mutations are ‘drivers’ further suggests that while breast
cancer shows almost an equal number of driver and passenger mutations other cancer types are more enriched for ‘drivers’ — at least in the COSMIC
dataset.
doi:10.1371/journal.pone.0068370.g002
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Generation of the cancer datasets
6724 non-synonymous cancer mutations were extracted from
version v44 of the COSMIC dataset [24]. A dataset developed for
the creation of the cancer-associated missense mutation predictor
CanPredict [15] was downloaded from http://share.gene.com/
mutation_classification/. The CanPredict dataset consists of
cancer mutations from the COSMIC cancer dataset [31] which
are assumed to be driver mutations and SNPs from dbSNP [21]
with a minor allele frequencyw20% assumed to mimic passenger
mutations. This dataset is publicly available in our web server.
Generation of SIFT PSSMs
PSSMs were generated based on the previously mentioned PSI-
BLAST run and for comparison PSSMs were also generated based
on the alignment produced by SIFT using nr for the retrieval of
related sequences and a median conservation score of 2.75. The
SIFT PSSM was calculated by generating SIFT scores for all 20
standard amino acid symbols for all positions in the given protein:
SIFTscorei,j~
Pi,j
max
j
Pi,j
where SIFTscorei,j and Pi,j are the SIFT score and frequency,
respectively, for the j’th standard amino acid symbol at position ‘i’
in the protein. Next scores were converted into probabilities for
each position by dividing the score for the j’th standard amino acid
symbol at position ‘i’ in the protein by the sum of all scores for the
given i’th position:
Pi,j~
SIFTscorei,jP
j
SIFTscorei,j
The probabilities were finally converted to log-odds scores by
use of Blosum62 background frequencies. If a probability was zero
then the minimum Blosum62 matrix log-odds score of 24 was
used.
Description of the classification features
The optimal input to the ANNs based on the data in the PSSM
for the position of the SNP site was found to be:
N The 20 standard amino acid log-odds scores.
N The native amino acid log-odds score.
N The mutant amino acid log-odds score.
N The SIFT score for the mutation.
N The conservation score (Rc) for the given position.
N The median conservation score (RcMedian) calculated for the
whole protein.
N The relative surface accessibility (RSA) and the associated
reliability score for the mutated position and its two
neighbouring positions as calculated in NetSurfP [28].
This gives an extensive input feature space containing 31 input
features in each of the ANNs used to build NetDiseaseSNP.
During testing of different input features the 20 standard amino
acid log-odds scores and the log-odds scores for the SNP and
native amino acids were the basic input features to which the other
input features were added iteratively.
The log-odds scores for the 20 standard amino acid symbols and
the native and SNP amino acids were taken from the PSSMs
generated from the alignment produced by SIFT. However, when no
SIFT prediction was available for the given SNP either because the
protein is longer than 2000 amino acids or SIFT was not able to
generate an alignment then Blosum62matrix values were used for the
log-odds scores and also for probabilities in the input to the ANNs.
The SIFT score for the SNP amino acid was calculated as the
frequency of the SNP amino acid divided by the frequency of the
most frequently occurring amino acid at the SNP position in the
alignment - the SIFT score is thus a normalized probability.
A measure of the conservation at position ‘i’ in an alignment is
given by:
Rci~ log2 20ð Þz
X
j
Pi,j log2 Pi,j
where Rci is the conservation score at position ‘i’ and Pi,j is the
frequency at position ‘i’ for standard amino j in the PSSM for the
protein. The conservation score is calculated for every position in
the protein and the median value is used as input to the ANNs.
Furthermore, the conservation score for the SNP position is also
used as input to the ANNs.
The PSSM generated from the SIFT alignment is used by
NetSurfP [28] to predict the surface accessibility for the native
query protein without the SNP changes. The RSA-value and
reliability score for RSA-value predicted by NetSurfP for the SNP
position and the context in position -1 and +1 with respect to the
SNP site is then used as input to the ANNs.
Training of the classifier and evaluation of its
performance
A standard feed forward architecture was used for the ANNs
[10]. The ANNs thus comprised an input layer connected to a
hidden layer and finally a single output neuron producing the
output score. The back-propagation algorithm [32] was used for
training the ANNs.
Cross-validation and a running evaluation were used to estimate
the performance of the ANNs. In the cross-validation procedure,
the dataset is divided into n parts. One part is then selected for
testing of the performance of the ANN during training, one part is
selected for running evaluation, whereas the other n{2 parts are
used for training the ANN. This procedure is repeated n n{1ð Þ
times, thus using each of the n parts as a test set and running
evaluation set. Consequently, the training dataset was split into
four subsets for cross-validation. All SNPs from the same protein
were placed in the same subset. This avoids overtraining of the
ANNs due to non-biologically biases in the dataset related to
specific proteins — such as e.g. protein length related features.
Furthermore in order to balance the dataset proteins were
partitioned in such a way that the subsets would approximately
contain the same total number of SNPs and the same number of
neutral and disease SNPs.
In order to provide an evaluation of the performance, we used 6
different measures commonly used for this purpose. They were
reviewed in detail in a recent publication [29] and are described as
follows:.
Accuracy~
TPzTN
TNzTPzFPzFN
Precision~PPV~
TP
TPzFP
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Sensitivity~Recall~
TP
TPzFN
Specificity~
TN
TNzFP
Fscore~2:
Precision:Recall
PrecisionzRecall
MCC~
TP:TN{FP:FNﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TPzFPð Þ TPzFNð Þ TNzFPð Þ TNzFNð Þp
where TP is the number of correctly predicted disease SNPs (true
positives), TN the number of correctly predicted neutral SNPs
(true negatives), FP the number of SNPs falsely predicted to be
disease SNPs (false positives), and FN the number of SNPs falsely
predicted to be neutral SNPs (false negatives). The final MCC is
calculated from the independent evaluation subsets only.
The best ANN architecture and best performing input features
were selected by optimizing MCC based on sequences in the test
sets.
Softening of target values
When the optimal input to the ANNs had been found, the target
values in the training set were optimized by a procedure we call
softening of target values which was developed during this study.
In this procedure the target values of the most incorrectly
predicted SNPs in the test, is modified with a new target value
which is closer to the threshold value of 0.5 thereby reducing the
contribution of these SNPs to the error function in the back-
propagation algorithm. The new target values for these SNPs were
calculated by the empirical formulas:
FNs : new target value~1{ 0:5{avoutð Þ
FPs : new target value~0z avout{0:5ð Þ
where avout is the average output value calculated for the test set
in the cross-validation procedure. The most wrongly predicted
SNPs were found by first selecting a cut-off on test average output
values corresponding to a sensitivity and specificity of 95%. ANNs
were then trained again as described above. The sensitivity and
specificity cut-offs were then lowered in steps of 5% and new
ANNs trained after each step where the target values in the
training set were ‘softened’ by the two formula mentioned above
based on the test set average output values from the previous step
in the procedure. When the sensitivity and specificity cut-offs
reached a value of 80% some of the new target values calculated
by the formulas above started to change category (disease/neutral).
The new target values were then recalculated for steps of 1% from
the start value of 85% for the specificity and sensitivity cut-offs,
however ANNs were not retrained after these steps. No changes in
category were found for any SNPs for a sensitivity and specificity
cut-off of 83%— so a sensitivity and specificity of 83% was used as
the last step in the softening of target values procedure. For this
last step the number of hidden neurons was varied between:
0,2, . . . ,40 thus increasing the maximal number of hidden neurons
during training allowing for more complex learning after the
training set had been cleaned up. Furthermore, the three highest
ranking sets of three ANNs with the same evaluation set were
selected resulting in 3:4:3~36 ANNs instead of 4:3~12 ANNs
since averaging output from more well performing ANNs will
generally give a higher performance.
Supporting Information
File S1 This file contains three supporting tables. Table
S1aa Performance of NetDiseaseSNP. (1) All SNPs where
NetDiseaseSNP and SIFT agree on the prediction; (2) All SNPs
where NetDiseaseSNP and SIFT disagree on the prediction; (3) All
SNPs where SIFT is not able to generate a prediction; (4) All
SNPs. Table S1ab Performance of SIFT. (1) All SNPs where
NetDiseaseSNP and SIFT agree on the prediction; (2) All SNPs
where NetDiseaseSNP and SIFT disagree on the prediction; (3) All
SNPs where SIFT can generate a prediction. Table S1ba
Performance of NetDiseaseSNP. (1) All SIFT data encoded SNPs
where NetDiseaseSNP and SIFT agree on the prediction; (2) All
SIFT data encoded SNPs where NetDiseaseSNP and SIFT
disagree on the prediction; (3) All SIFT data encoded SNPs.
Table S1bb Performance of SIFT. (1) All SIFT data encoded
SNPs where NetDiseaseSNP and SIFT agree on the prediction; (2)
All SIFT data encoded SNPs where NetDiseaseSNP and SIFT
disagree on the prediction; (3) All SIFT data encoded SNPs where
SIFT can generate a prediction. Table S1ca Performance of
NetDiseaseSNP. (1) All Blosum62 data encoded SNPs where
NetDiseaseSNP and SIFT agree on the prediction; (2) All
Blosum62 data encoded SNPs where NetDiseaseSNP and SIFT
disagree on the prediction; (3) All Blosum62 data encoded SNPs
where SIFT is not able to generate a prediction; (4) All Blosum62
data encoded SNPs. Table S1cb Performance of SIFT. (1) All
Blosum62 data encoded SNPs where NetDiseaseSNP and SIFT
agree on the prediction; (2) All Blosum62 data encoded SNPs
where NetDiseaseSNP and SIFT disagree on the prediction; (3) All
Blosum62 data encoded SNPs where SIFT can generate a
prediction. Table S1da Performance of NetDiseaseSNP. (1) All
Blosum62 data encoded SNPs where SIFT predictions exist and
NetDiseaseSNP and SIFT agree on the prediction; (2) All
Blosum62 data encoded SNPs where SIFT predictions exist and
NetDiseaseSNP and SIFT disagree on the prediction; (3) All
Blosum62 data encoded SNPs where SIFT predictions exist.
Table S1db Performance of SIFT. (1) All Blosum62 data
encoded SNPs where SIFT predictions exist and NetDiseaseSNP
and SIFT agree on the prediction; (2) All Blosum62 data encoded
SNPs where SIFT predictions exist and NetDiseaseSNP and SIFT
disagree on the prediction; (3) All Blosum62 data encoded SNPs
where SIFT predictions exist and SIFT can generate a prediction.
Table S1e Number of neutral and disease SNPs for each of
different types of encoding for SNPs. The columns in the table are:
Column 1: Input data to NetDiseaseSNP; Column 2: Protein is
longer than 2000 amino acids; Column 3: SIFT data exists for the
all SNPs; Column 4: Number of neutral SNPs; Column 5:
Number of disease SNPs. The rows in the table are: (1) All SNPs
both SIFT and Blosum62 data encoded SNPs; (2) SIFT data
encoded SNPs; (3) Blosum62 data encoded SNPs; (4) Blosum62
data encoded SNPs where SIFT output data exists i.e. protein is
longer than 2000 amino acids; (5) Blosum62 data encoded SNPs
where SIFT output data does not exist. Table S2a Predictions by
NetDiseaseSNP and SIFT. The rows in the table are: (1) Both
NetDiseaseSNP and SIFT predict disease; (2) Both NetDisea-
seSNP and SIFT predict neutral; (3) NetDiseaseSNP predicts
disease and SIFT predicts neutral; (4) NetDiseaseSNP predicts
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neutral and SIFT predicts disease; (5) NetDiseaseSNP predicts
disease and SIFT no prediction; (6) NetDiseaseSNP predicts
neutral and SIFT no prediction; (7) Total number of mutations.
Table S2b Predictions by NetDiseaseSNP on mutations where
NetDiseaseSNP predicts the mutation to be a disease mutation
and mutations are encoded with Blosum62 matrix data. The
columns in the table are: Column 1: Description of the data in the
row; Column 2: Protein is longer than 2000 amino acids; Column
3: All mutations at all positions in the protein are encoded with
Blosum62 matrix data. The rows in the table are: (1) Protein
longer than 2000 amino acids; (2) SIFT is not able to generate
output for any mutation in this protein and the protein is shorter
than 2000 amino acids; (3) SIFT is able to generate output for
some mutations in this protein and the protein is shorter than 2000
amino acids; (4) Total number of mutations. Table S2c
Predictions by NetDiseaseSNP on mutations where NetDisea-
seSNP predicts the mutation to be a neutral mutation and
mutations are encoded with Blosum62 matrix data. The columns
in the table are: Column 1: Description of the data in the row;
Column 2: Protein is longer than 2000 amino acids; Column 3: All
mutations at all positions in the protein are encoded with
Blosum62 matrix data. The rows in the table are: (1) Protein
longer than 2000 amino acids; (2) SIFT is not able to generate
output for any mutation in this protein and the protein is shorter
than 2000 amino acids; (3) SIFT is able to generate output for some
mutations in this protein and the protein is shorter than 2000 amino
acids; (4) Total number of mutations. Table S3a Performance of
NetDiseaseSNP. (1) All mutations where NetDiseaseSNP and SIFT
agree on the prediction; (2) All mutations where NetDiseaseSNP
and SIFT disagree on the prediction; (3) All mutations where SIFT
is not able to generate a prediction; (4) All mutations. Table S3b
Performance of SIFT. (1) All mutations where NetDiseaseSNP and
SIFT agree on the prediction; (2) All mutations where NetDisea-
seSNP and SIFT disagree on the prediction; (3) All mutations where
SIFT can generate a prediction.
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